Maria Perez-Lanzon
7PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Jan 20, 2025
Epigenetic regulation of HOXA2 expression affects tumor progression and predicts breast cancer patient survival.Fatima Domenica Elisa De Palma, Jonathan G Pol, Vincent Carbonnier
|Feb 20, 2024
Correction: Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line.Maria Perez-Lanzon, Maria Chiara Maiuri, Carlos Lopez-Otin
|Jan 13, 2024
Preclinical models of breast cancer: B6BC, a transplantable hormone receptor-positive C57BL/6 mouse cell line.Maria Perez-Lanzon, Maria Chiara Maiuri, Carlos Lopez-Otin
|Oct 10, 2022
PDIA3 as a potential bridge between immunogenic cell death and autoreactivity.Jonathan G Pol, Céleste Plantureux, María Pérez-Lanzón
|Oct 29, 2021
Crizotinib and ceritinib trigger immunogenic cell death via on-target effects.Adriana Petrazzuolo, Maria Perez-Lanzon, Peng Liu
|Oct 25, 2019
Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity.Wei Xie, Sabrina Forveille, Kristina Iribarren
Pageof 2
Frequent Collaborators
7 joint publications
Guido Kroemer
3 joint publications
Maria Chiara Maiuri
2 joint publications
Allan Sauvat
2 joint publications
Jonathan G Pol
1 joint publications
Kristina Iribarren
1 joint publications
Oliver Kepp
1 joint publications
Peng Liu
1 joint publications
Céleste Plantureux
1 joint publications
Fatima Domenica Elisa De Palma
1 joint publications
Léa Montégut
